Primary Device ID | 04250289502832 |
NIH Device Record Key | 961c6424-b5f7-4787-aa9f-955434ca9f8f |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | AESKULISA® ß2-Glyco-GM |
Version Model Number | 30-7206US |
Catalog Number | 30-7206US |
Company DUNS | 341714388 |
Company Name | Aesku.Diagnostics GmbH & Co. KG |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | true |
Device Combination Product | false |
Single Use | true |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | false |
OTC Over-The-Counter | false |
Storage Environment Temperature | Between 2 Degrees Celsius and 8 Degrees Celsius |
Device Issuing Agency | Device ID |
---|---|
GS1 | 04250289502832 [Primary] |
MSV | System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi) |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 3 |
Public Version Date | 2018-07-06 |
Device Publish Date | 2017-02-28 |
04250289503082 | AESKULISA β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2glycoproteinI hig |
04250289502832 | AESKULISA β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2glycoproteinI hig |
04250289500869 | AESKULISA β2-Glyco-GM is a solid phase enzyme immunoassay employing native β2glycoproteinI hig |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
AESKULISA 76374617 2878292 Live/Registered |
Matthias, Torsten 2002-02-22 |